Related Experiment Video
Updated: Aug 8, 2026

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro
Published on: March 18, 2014
Triggered All-Active Metal Organic Framework: Ferroptosis Machinery Contributes to the Apoptotic Photodynamic
Xuan Meng1, Jian Deng1, Fang Liu1
1School of Pharmaceutical Science & Technology, Tianjin Key Laboratory for Modern Drug Delivery & High Efficiency, and Collaborative Innovation Center of Chemical Science and Engineering (Tianjin) , Tianjin University , Tianjin 300072 , China.
Abstract:
Nanoscale photodynamic therapy (PDT) is an appealing antitumor modality for which apoptosis is the major mechanism of toxicity induction. It was postulated that the highly reactive singlet oxygen in PDT could deplete glutathione (GSH) and activate ferroptosis, the extent to which could be further manipulated by a redox-responsive nanocarrier. To validate this, a disulfide-bearing imidazole ligand coordinated with zinc to form an all-active metal organic framework (MOF) nanocarrier where a photosensitizer (chlorin e6/Ce6) was encapsulated. Regardless of light irradiation, the Ce6-loaded nanocarrier caused the depletion of intracellular GSH via the disulfide-thiol exchange reaction in a murine mammary carcinoma cell line (4T1). The GSH depletion further caused the inactivation of glutathione peroxide 4 (GPX4) and the enhancement of cytotoxicity that was alleviated by ferroptosis inhibitors. The superior in vivo antitumor efficacy of the all-active nanocarrier was corroborated in a 4T1 tumor-bearing mice model regarding tumor growth suppression and animal survival rate. The coadministration of an iron chelator weakened the antitumor potency of the nanocarrier due to ferroptosis inhibition, which was supported by the fact of tumor growth upsurge and the recovered GPX4 activity. The current work highlights the contribution of ferroptotic machinery to antitumor PDT via an activatable, adaptable, all-active MOF nanocarrier.
Insights
This study shows that a novel nanocarrier enhances photodynamic therapy (PDT) by depleting glutathione (GSH) and inducing ferroptosis, leading to effective tumor suppression in mice.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Cancer Therapy
Background:
- Photodynamic therapy (PDT) is a promising cancer treatment, primarily inducing apoptosis.
- The role of ferroptosis in PDT and its manipulation via nanocarriers remain areas for exploration.
Purpose of the Study:
- To investigate the potential of a redox-responsive nanocarrier to induce ferroptosis alongside PDT.
- To validate the contribution of ferroptosis to the antitumor efficacy of nanoscale PDT.
Main Methods:
- Fabrication of a disulfide-bearing metal-organic framework (MOF) nanocarrier encapsulating chlorin e6 (Ce6).
- Assessment of intracellular glutathione (GSH) depletion, glutathione peroxide 4 (GPX4) inactivation, and cytotoxicity in 4T1 cells.
- Evaluation of in vivo antitumor efficacy and ferroptosis inhibition in a 4T1 tumor-bearing mice model.
Main Results:
- The Ce6-loaded MOF nanocarrier depleted intracellular GSH and induced ferroptosis, independent of light.
- GSH depletion led to GPX4 inactivation and enhanced cytotoxicity, which was reversible with ferroptosis inhibitors.
- The nanocarrier demonstrated significant in vivo antitumor efficacy, suppressed tumor growth, and improved survival rates in mice.
Conclusions:
- The developed all-active MOF nanocarrier effectively induces ferroptosis, contributing significantly to antitumor PDT.
- Targeting ferroptosis presents a viable strategy to enhance the efficacy of nanoscale photodynamic therapy.
More Related Videos
Related Concept Videos
Apoptosis
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become anucleated and die, but their...
Cellular Injury V: Apoptosis and Autophagy

